Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.36

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (15109)	2/14/1998 7:56:00 PM
From: squetch	Read Replies (2) of 32384

Henry, >>prevention trial<< I was thinking more about off label usage. My understanding is prevention trials are long and expensive. I think the off label usage would be possible after decent human therapeutic data. It appears to me a low dose might be worth the risk/reward to some high risk patients and their doctors. I feel I am being a "board hog". Sorry everybody. I find this info very exciting. I don't think Lehman or Charles Engelberg read the paper. I will see if I can dig up any human Tamox data. I find myself wishing very much to see the human Targretin data for diabetes. Won't this usage in a chronic condition eventually, and hopefully, establish Targretin's safety profile.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next